Jialin Bs Deng

Jialin Bs Deng

Auto-generated profile, based on publicly available information

Jialin Bs Deng

Nursing Department of Chongqing University Jiangjin Hospital, Chongqing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2021 in Medicine
Verified
Journal Article
Open access
KFKai Feng
Kai Feng
YZYing Zhao
Ying Zhao
QYQingyang Yu
Qingyang Yu
JDJialin Deng
Jialin Deng
JWJingjing Wu
Jingjing Wu
LLLingjia Mm Liu
Lingjia Mm Liu
Introduction: Autism spectrum disorder (ASD) is a neurodevelopmental disorder with increasing incidence. The externalizing and internalizing problems among children with ASD often persistent and highly impair functioning of both the child and the family. Children with ASD often develop gut-related comorbidities and dysbiosis can have negative effects on not only the gastrointestinal (GI) tract, but also psychological symptoms. Dietary exclusions and probiotic supplements also have been investigated in the management of ASD symptoms. Especially, there is some anecdotal evidence that probiotics supplements are able to alleviate GI symptoms as well as improve behaviors in children with ASD. Method and analysis: This review will report on overall studies that include randomized control trials, randomized cross-over studies and cluster-randomized trials designs that consider curative effect in children with ASD by probiotic supplements. We will search 6 databases: MEDLINE, Embase, Scopus, PubMed, The Cochrane Library, and Web of Science and we will perform a manual search the journal Autism and information of ongoing or unpublished studies. The Mixed Methods Appraisal Tool (MMAT) will be used to assess quality of articles and the Jadad scale will be used to assess for bias. Assessment of publication bias will be performed using funnel plots generated by Comprehensive Meta-Analysis (CMA) 3.0 software. Clarifying the evidence in this area will be important for future research directions when reformulating and promoting the therapeutic regime in the field. Ethics and dissemination: There are no human participants, data, or tissue being directly studied for the purposes of the review; therefore, ethics approval and consent to participate are not applicable. The results of this study will be presented at conferences and published in peer-reviewed journals. Registration and status: PROSPERO 2019 CRD42019132754.

17 May 2024 in Medicine
Verified
Journal Article
Open access
YGYunqing Bs Guo
Yunqing Bs Guo
XXXiaojing Bs Xia
Xiaojing Bs Xia
JDJialin Bs Deng
Jialin Bs Deng
Background: The efficacy of fascia iliaca block (FIB) versus quadratus lumborum block (QLB) remains controversial for pain management of hip arthroplasty. We conduct a systematic review and meta-analysis to explore the influence of FIB versus QLB on the postoperative pain intensity of hip arthroplasty. Methods: We have searched PubMed, EMbase, Web of Science, EBSCO, and Cochrane Library databases through July 2023 for randomized controlled trials assessing the effect of FIB versus QLB on pain control of hip arthroplasty. This meta-analysis is performed using the random-effect model or fixed-effect model based on the heterogeneity. Results: Four randomized controlled trials and 234 patients were included in the meta-analysis. Overall, compared with QLB for hip arthroscopy, FIB was associated with substantially lower pain scores at 2 hours (mean difference [MD] = –0.49; 95% CI = –0.63 to –0.35; P < .00001) and pain scores at 12 hours (MD = –0.81; 95% CI = –1.36 to –0.26; P = .004), but showed no impact on pain scores at 24 hours (MD = –0.21; 95% CI = –0.57 to 0.15; P = .25), time to first rescue analgesia (standard mean difference = 0.70; 95% CI = –0.59 to 1.99; P = .29), analgesic consumption (MD = –4.80; 95% CI = –16.57 to 6.97; P = .42), or nausea and vomiting (odd ratio = 0.66; 95% CI = 0.32–1.35; P = .25). Conclusions: FIB may be better than QLB for pain control after hip arthroplasty, as evidenced by the lower pain scores at 2 and 24 hours.